Weikang Bio-Technology Group Company, Inc is principally engaged in developing, manufacturing and distributing health and nutritional supplements in China. The company has also expanded its business scope to develop, manufacture and distribute Chinese herbal extract products and GMP certified western prescriptive medicine. They recently filed for an initial public offering of their shares.The principal offices are located at in the “Economic & Technology Development Zone” Heilongjiang Province, The People’s Republic of China. They will not receive any proceeds from the sale of the 2,095,588 shares of common stock. However, they may receive the sale price of any common stock they sell to the selling stockholders upon exercise of the outstanding warrants.

During the year ended December 31, 2009, they had sales of $47.48 million, compared to $12.85 million for 2008, an increase of $34.63 million or 269%. Gross profit was $25.84 million for the year ended December 31, 2009, compared to $8.27 million for 2008, representing profit margins of 54% and 64% of sales, respectively.

—————–

A self underwritten offering is conducted by a private company and their advisers to provide shareholder liquidity, access investment capital, complete mergers and acquisitions using stock and to issue warrants to provide employees and third parties with an extra incentive. Contact Public Financial Services to learn more about the advantages, costs and timing to take your private company public!